Death Blamed on Uncommunicated Abnormal PSA Results

November 7, 2023 | Strategic Insights for Ambulatory Care

Preview

In 2009, a patient (plaintiff/decedent) with a family history of prostate cancer was tested via a digital rectal exam (which was normal) and the prostate-specific antigen (PSA) lab test. The PSA test results were abnormally high. At trial, there was conflicting evidence as to whether this result was communicated to the patient, according to the September 2023 Medical Malpractice Verdicts, Settlements & Experts.  

Evidence was offered by the patient that a voicemail message was left for him but only results related to high cholesterol number was relayed; the defense claimed the PSA test results were also relayed at that time. For the next two years, there was no evidence offered demonstrating...

Access Full Content

Contact us today at 610.825.6000.